Open Access

Great debate on STEMI: current controversies on antiplatelet management after the acute phase

Event: Acute Cardiovascular Care 2018
Topic: Acute Coronary Syndromes
Session type: Debate Session
Date: 4 March 2018
Time: 14:00 - 15:30

Congress Session

10 presentations in this session

Risk scores are helpful for defining optimal DAPT duration - PRO.

Speaker: Professor S. De Servi (Sesto San Giovanni, IT)
Thumbnail

Risk scores are helpful for defining optimal DAPT duration - CONTRA.

Speaker: Professor A. Budaj (Warsaw, PL)
Thumbnail

Risk scores are helpful for defining optimal DAPT duration - Rebuttal PRO.

Speaker: Professor S. De Servi (Sesto San Giovanni, IT)
Thumbnail

Risk scores are helpful for defining optimal DAPT duration - Rebuttal CONTRA.

Speaker: Professor A. Budaj (Warsaw, PL)
Thumbnail

Risk scores are helpful for defining optimal DAPT duration: Chairpersons conclusion.

Thumbnail

It is time to reconsider aspirin as a routine therapy for secondary prevention after STEMI - PRO.(Via ZOOM)

Speaker: Professor P. Vranckx (Hasselt, BE)
Thumbnail

It is time to reconsider aspirin as a routine therapy for secondary prevention after STEMI - CONTRA.

Speaker: Professor F. Verheugt (Amsterdam, NL)
Thumbnail

It is time to reconsider aspirin as a routine therapy for secondary prevention after STEMI - Rebuttal PRO. .(Via ZOOM)

Speaker: Professor P. Vranckx (Hasselt, BE)
Thumbnail

It is time to reconsider aspirin as a routine therapy for secondary prevention after STEMI - Rebuttal CONTRA.

Speaker: Professor F. Verheugt (Amsterdam, NL)
Thumbnail

It is time to reconsider aspirin as a routine therapy for secondary prevention after STEMI: chairpersons conclusion.

Thumbnail

8 speakers from this session

Professor Stefano De Servi

IRCCS MultiMedica, Sesto San Giovanni (Italy)
3 presentations
1 follower

Professor Andrzej Budaj

Grochowski Hospital, Centre of Postgraduate Medical School, Warsaw (Poland)
3 presentations
0 follower

Professor Stefano De Servi

IRCCS MultiMedica, Sesto San Giovanni (Italy)
3 presentations
1 follower

Professor Andrzej Budaj

Grochowski Hospital, Centre of Postgraduate Medical School, Warsaw (Poland)
3 presentations
0 follower

Professor Pascal Vranckx

Heart Centre Hasselt, Hasselt (Belgium)
22 presentations
0 follower

Professor Freek Verheugt

Onze Lieve Vrouwe Gasthuis, Amsterdam (Netherlands (The))
21 presentations
0 follower

Professor Pascal Vranckx

Heart Centre Hasselt, Hasselt (Belgium)
22 presentations
0 follower

Professor Freek Verheugt

Onze Lieve Vrouwe Gasthuis, Amsterdam (Netherlands (The))
21 presentations
0 follower

This platform is supported by

logo Novo Nordisk